We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




DNA Biosensor Enables Early Diagnosis of Cervical Cancer

By LabMedica International staff writers
Posted on 21 Dec 2023
Print article
Image: The electrochemical sensor detects HPV-16 and HPV-18 with high specificity (Photo courtesy of 123RF)
Image: The electrochemical sensor detects HPV-16 and HPV-18 with high specificity (Photo courtesy of 123RF)

Molybdenum disulfide (MoS2), recognized for its potential to form two-dimensional nanosheets like graphene, is a material that's increasingly catching the eye of the scientific community. These nanosheets are formed through the stacking of S–Mo–S layers that are held together by Van der Waals forces. MoS2's distinctive structural, optical, thermal, and electrochemical attributes have paved the way for research in diverse domains, including biomolecule sensing, optoelectronics, energy storage, and more. Historically, carbon nanostructures have been used as an immobilization platform for DNA. To replace carbon with MoS2 as an effective electrochemical DNA sensor, the electrical conductivity of MoS2 must be improved significantly.

To tackle this challenge, researchers at Chung-Ang University (Seoul, South Korea) have devised an electrochemical DNA biosensor using a composite of graphitic nano-onions and MoS2 nanosheets. This biosensor shows promise in detecting human papillomavirus (HPV) types 16 and 18, offering the potential for early cervical cancer diagnosis. The team measured the biosensor's sensitivity to these HPV types using the differential pulse voltammetry (DPV) technique in conjunction with methylene blue (MB) as a redox indicator. They observed that the nano-onion/MoS2 nanosheet composite electrode demonstrated higher current peaks than its MoS2-only counterpart, suggesting enhanced conductive electron transfer facilitated by the nano-onions.

This enhancement led to the effective and specific detection of target DNAs from HPV-16 and HPV-18 Siha and Hela cancer cell lines. As a result, MoS2 nanosheets with improved electrical conductivity, when combined with nano-onions, have shown potential as a robust platform for creating electrochemical biosensors that can efficiently diagnose various health conditions, including cervical cancer. Moreover, the integration of nano-onions or nanodiamonds with various organic biomaterials could lead to advancements in chemical functionality, electron transfer conductivity, light absorption, and more. These developments hold promise for groundbreaking applications in disease sensing, targeted drug delivery, and biomedical imaging and diagnostics.

Related Links:
Chung-Ang University 

New
Gold Member
ZIKA Virus Test
ZIKA ELISA IgG
Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
New
Gastrin-17 ELISA
Human Gastrin-17 CLIA Kit
New
RNA Isolation Kits
RNeasy Plus Kits for RNA Isolation

Print article

Channels

Immunology

view channel
Image: Example image of the high-throughput microscopy method used in the study, showing immune cells stained with different fluorescence markers (Photo courtesy of Felix Kartnig/CeMM, MedUni Vienna)

Cutting-Edge Microscopy Technology Enables Tailored Rheumatology Therapies

Rheumatoid arthritis is the most common inflammatory joint disorder, with women three times as likely to suffer from the condition as men. Treatment advances made over the past decades have led to the... Read more

Microbiology

view channel
Image: RNA sequencing directly from whole blood aims to expand access to LRTI testing (Photo courtesy of CARB-X)

Novel Test to Diagnose Bacterial Pneumonia Directly from Whole Blood

Pneumonia and lower-respiratory-tract infections (LRTIs) are among the top causes of illness and death globally, particularly in vulnerable populations such as the elderly, young children, and immunocompromised... Read more

Pathology

view channel
Image: Lunit SCOPE HER2 is an AI-powered solution designed to detect HER2 expression profile (Photo courtesy of Lunit)

AI-Powered Pathology Solutions Accurately Predict Outcomes for HER2-Targeted Therapy in Metastatic CRC

A new study has highlighted how artificial intelligence (AI)-powered analysis of HER2 and the tumor microenvironment (TME) can improve patient stratification and predict clinical outcomes more effectively.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.